These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24283220)

  • 21. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
    Spire B; Lucas GM; Carrieri MP
    Int J Drug Policy; 2007 Aug; 18(4):262-70. PubMed ID: 17689374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users.
    Chakrapani V; Kamei R; Kipgen H; Kh JK
    Int J Prison Health; 2013; 9(2):82-91. PubMed ID: 25758440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ART access-related barriers faced by HIV-positive persons linked to care in southern Ghana: a mixed method study.
    Ankomah A; Ganle JK; Lartey MY; Kwara A; Nortey PA; Okyerefo MP; Laar AK
    BMC Infect Dis; 2016 Dec; 16(1):738. PubMed ID: 27927183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in HIV disease progression by injecting drug use in HIV-infected persons in care.
    Moore RD; Keruly JC; Chaisson RE
    J Acquir Immune Defic Syndr; 2004 Jan; 35(1):46-51. PubMed ID: 14707791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Facilitators and barriers for retention in HIV care between testing and treatment in Asia-A study in Bangladesh, Indonesia, Lao, Nepal, Pakistan, Philippines and Vietnam.
    Koirala S; Deuba K; Nampaisan O; Marrone G; Ekström AM;
    PLoS One; 2017; 12(5):e0176914. PubMed ID: 28459881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India.
    Ganju D; Ramesh S; Saggurti N
    Harm Reduct J; 2016 Jun; 13(1):21. PubMed ID: 27324253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5").
    Aceijas C; Oppenheimer E; Stimson GV; Ashcroft RE; Matic S; Hickman M
    Addiction; 2006 Sep; 101(9):1246-53. PubMed ID: 16911723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatial distribution and characteristics of injecting drug users (IDU) in five Northeastern states of India.
    Medhi GK; Mahanta J; Adhikary R; Akoijam BS; Liegise B; Sarathy K; Thomas CJ; Sarmah B
    BMC Public Health; 2011 Jan; 11():64. PubMed ID: 21281465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homelessness and psychological distress as contributors to antiretroviral nonadherence in HIV-positive injecting drug users.
    Waldrop-Valverde D; Valverde E
    AIDS Patient Care STDS; 2005 May; 19(5):326-34. PubMed ID: 15916495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study.
    Kiriazova T; Go VF; Hershow RB; Hamilton EL; Sarasvita R; Bui Q; Lancaster KE; Dumchev K; Hoffman IF; Miller WC; Latkin CA
    Harm Reduct J; 2020 Oct; 17(1):69. PubMed ID: 32998731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multilevel determinants of antiretroviral therapy initiation and retention in the test-and-treat era of Nepal: a qualitative study.
    Shrestha A; Poudel L; Shrestha S; Jha N; Kuikel BS; Shakya P; Kunwar RS; Pandey LR; Kc MB; Wilson EC; Deuba K
    BMC Health Serv Res; 2024 Aug; 24(1):927. PubMed ID: 39138448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Access, adherence, quality and impact of ARV provision to current and ex-injecting drug users in Manipur (India): an initial assessment.
    Sharma M; Singh RR; Laishram P; Kumar B; Nanao H; Sharma C; Ahmed T
    Int J Drug Policy; 2007 Aug; 18(4):319-25. PubMed ID: 17689381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward.
    Wolfe D; Carrieri MP; Shepard D
    Lancet; 2010 Jul; 376(9738):355-66. PubMed ID: 20650513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.
    Mathers BM; Degenhardt L; Ali H; Wiessing L; Hickman M; Mattick RP; Myers B; Ambekar A; Strathdee SA;
    Lancet; 2010 Mar; 375(9719):1014-28. PubMed ID: 20189638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlates of injecting in an HIV incidence hotspot among substance users in Tijuana, Mexico.
    Kori N; Roth AM; Lozada R; Vera A; Brouwer KC
    Int J Drug Policy; 2014 May; 25(3):525-32. PubMed ID: 24418632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV care engagement and ART adherence among Kenyan gay, bisexual, and other men who have sex with men: a multi-level model informed by qualitative research.
    Graham SM; Micheni M; Secor A; van der Elst EM; Kombo B; Operario D; Amico KR; Sanders EJ; Simoni JM
    AIDS Care; 2018 Aug; 30(sup5):S97-S105. PubMed ID: 30668136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reaching out beyond the hills: HIV prevention among injecting drug users in Manipur, India.
    Hangzo C; Chatterjee A; Sarkar S; Zomi GT; Deb BC; Abdul-Quader AS
    Addiction; 1997 Jul; 92(7):813-20. PubMed ID: 9293040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Test but not treat: Community members' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa.
    Iwuji C; Chimukuche RS; Zuma T; Plazy M; Larmarange J; Orne-Gliemann J; Siedner M; Shahmanesh M; Seeley J
    PLoS One; 2020; 15(9):e0239513. PubMed ID: 32970730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with antiretroviral treatment uptake and adherence: a review. Perspectives from Australia, Canada, and the United Kingdom.
    Bolsewicz K; Debattista J; Vallely A; Whittaker A; Fitzgerald L
    AIDS Care; 2015; 27(12):1429-38. PubMed ID: 26641139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.